Literature DB >> 15297472

Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years.

Ralf D Hess1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15297472      PMCID： PMC497621          DOI： 10.1128/JCM.42.8.3381-3387.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  31 in total

1.  Themed issue: the biology and pathology of the Epstein-Barr virus.

Authors:  P G Murray; L S Young
Journal:  Mol Pathol       Date:  2000-10

2.  Evaluation of a recombinant line blot for diagnosis of Epstein-Barr Virus compared with ELISA, using immunofluorescence as reference method.

Authors:  B C Gärtner; J M Fischinger; K Roemer; M Mak; B Fleurent; N Mueller-Lantzsch
Journal:  J Virol Methods       Date:  2001-04       Impact factor: 2.014

3.  Antibodies to Epstein-Barr virus-induced early antigens in blood donors.

Authors:  P Wohlrabe; I Färber; P Wutzler; R Uhlig
Journal:  Acta Virol       Date:  1989-08       Impact factor: 1.162

Review 4.  The EB virus.

Authors:  M A Epstein; B G Achong
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis.

Authors:  P D White; J M Thomas; H O Kangro; W D Bruce-Jones; J Amess; D H Crawford; S A Grover; A W Clare
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

7.  Enzyme-linked immunosorbent assay for IgG antibodies to Epstein-Barr virus-associated early antigens and viral capsid antigen.

Authors:  G Dölken; U Weitzmann; C Boldt; M Bitzer; W Brugger; G W Löhr
Journal:  J Immunol Methods       Date:  1984-03-16       Impact factor: 2.303

8.  A systematic study of Epstein-Barr virus serologic assays following acute infection.

Authors:  Thomas D Rea; Rhoda L Ashley; Joan E Russo; Dedra S Buchwald
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

9.  Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.

Authors:  A Linde; B Kallin; J Dillner; J Andersson; L Jägdahl; A Lindvall; B Wahren
Journal:  J Infect Dis       Date:  1990-05       Impact factor: 5.226

10.  A sensitive enzyme-linked immunosorbent assay (ELISA) against the major EBV-associated antigens. I. Correlation between ELISA and immunofluorescence titers using purified antigens.

Authors:  J Luka; R C Chase; G R Pearson
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303
View more
  59 in total

Review 1.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.

Authors:  O Coşkun; E Yazici; F Şahiner; A Karakaş; S Kiliç; M Tekin; C Artuk; L Yamanel; B A Beşirbellioğlu
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-07-19       Impact factor: 0.840

3.  Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.

Authors:  J Lupo; R Germi; T Semenova; M Buisson; J M Seigneurin; P Morand
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

Review 4.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

5.  An ELISA method to compute endpoint titers to Epstein-Barr virus and cytomegalovirus: application to population-based studies.

Authors:  Raymond P Stowe; R Jeanne Ruiz; Christopher P Fagundes; Robin H Stowe; Min Chen; Ronald Glaser
Journal:  J Immunol Methods       Date:  2014-05-22       Impact factor: 2.303

6.  High-dose dexamethasone therapy for severe thrombocytopenia and neutropenia induced by EBV infectious mononucleosis.

Authors:  Yuki Kagoya; Akira Hangaishi; Tsuyoshi Takahashi; Yoichi Imai; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-03       Impact factor: 2.490

7.  High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.

Authors:  Eric R Weiss; Galit Alter; Javier Gordon Ogembo; Jennifer L Henderson; Barbara Tabak; Yasin Bakiş; Mohan Somasundaran; Manuel Garber; Liisa Selin; Katherine Luzuriaga
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

8.  Stress-related Epstein-Barr virus reactivation.

Authors:  Omer Coskun; Kenan Sener; Selim Kilic; Hakan Erdem; Halil Yaman; Ahmet Bulent Besirbellioglu; Hanefi Cem Gul; Can Polat Eyigun
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

9.  Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women.

Authors:  Deepti Joshi; Munira Quadri; Neha Gangane; Rajnish Joshi; Nitin Gangane
Journal:  PLoS One       Date:  2009-12-04       Impact factor: 3.240

10.  Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" Pattern.

Authors:  Massimo De Paschale; Debora Cagnin; Teresa Cerulli; Maria Teresa Manco; Carlo Agrappi; Paola Mirri; Arianna Gatti; Cristina Rescaldani; Pierangelo Clerici
Journal:  Int J Microbiol       Date:  2010-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.